RX Product News: October 2023

Pharmacy TimesOctober 2023
Volume 89
Issue 10

The products include Abacavir/Dolutegravir/Lamivudine, Lisaftoclax (APG-2575), Zuranolone (Zurzuvae), Ebola Zaire Vaccine.


From: Viatris

Image credit: PHTM Retail- October 2023 Issue

Image credit: PHTM Retail- October 2023 Issue

The FDA has issued a tentative approval for once-daily abacavir 60 mg/dolutegravir 5 mg/ lamivudine 30 mg tablets for oral suspension to treat HIV-1 infection in pediatric patients weighing 6 kg to less than 25 kg. In a news release, the company noted that treating HIV-1 in pediatric patients can be challenging because they require unique medication formulations, making the fixed-dose, strawberry-flavored tablets for oral suspension an important new option. The combination contains 2 nucleoside reverse transcriptase inhibitors and an integrase strand transfer inhibitor.


Lisaftoclax (APG-2575)

From: Ascentage Pharma

The FDA granted clearance for lisaftoclax (APG-2575) with a Bruton tyrosine kinase (BTK) inhibitor for a phase 3 study in patients with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma who were previously treated with the BTK inhibitor. Lisaftoclax is an oral, small-molecule Bcl-2 selective inhibitor. Used with acalabrutinib (Calquence; AstraZeneca) in patients with R/R CLL, phase 2 trial participants experienced an objective response rate of 98%. Lisaftoclax used alone or with acalabrutinib showed manageable safety with adverse effects of neutropenia, diarrhea, and infections.


Zuranolone (Zurzuvae)

From: Sage Therapeutics

The FDA has approved zuranolone (Zurzuvae) as an oral postpartum depression treatment for adults. Zuranolone is intended to aid women coping with extreme and sometimes life-threatening feelings after childbirth. Two clinical studies—the SKYLARK study (NCT04442503) and ROBIN study (NCT02978326)—met all secondary end points with the use of zuranolone 40 mg and 50 mg, reducing depressive symptoms in 3 days. The most common adverse effects when taking 50 mg included somnolence, dizziness, diarrhea, fatigue, and urinary tract infections. Other warnings involve patients’ ability to drive and fetal harm. To prevent this, it is recommended that women use contraception while taking zuranolone and for 1 week after stopping treatment.


Ebola Zaire Vaccine

From: Merck

The FDA has approved an expanded indication for the Ebola Zaire vaccine, live (Ervebo), now including individuals aged 12 months and older. Once the vaccine is administered, the duration of protection is unknown, although the vaccine has been found to be 100% effective at preventing onset of symptoms after more than 10 days. In 2 clinical trials, the most common adverse events (AEs) were infection site pain, redness, and swelling. Other AEs in Study 1 included headache, fever, muscle pain, fatigue, nausea, joint pain/tenderness, rash, and abnormal sweating. Joint pain and rash were shared AEs in Study 1 and Study 2, although Study 2 included arthritis and vesicular lesions as well. None of the AEs were fatal.


Related Videos
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U - stock.adobe.com
Image credit: Andrea Izzotti
Inflation Reduction Act is shown using the text and the US flag - Image credit: Andrii | stock.adobe.com
Pharmacy Interior | Image Credit: Tyler Olson - stock.adobe.com
Male pharmacist selling medications at drugstore to a senior woman customer | Image Credit: Zamrznuti tonovi - stock.adobe.com
Pharmacist assists senior woman in buying medicine in pharmacy - Image credit: Drazen | stock.adobe.com
Pharmacy, medicine and senior woman consulting pharmacist on prescription. Healthcare, shopping and elderly female in consultation with medical worker for medication box, pills or product in store - Image credit: C Daniels/peopleimages.com | stock.adobe.com
Image credit: fidaolga - stock.adobe.com
Pharmacists checking inventory at hospital pharmacy- Image credit: Jacob Lund | stock.adobe.com
Young male pharmacist giving prescription medications to senior female customer in a pharmacy | Image Credit: Zamrznuti tonovi - stock.adobe.com
© 2023 MJH Life Sciences

All rights reserved.